Tadalafil attenuates spinal cord injury induced oxidative organ damage in rats
Abstract
Spinal cord injury (SCI) has been shown to cause systemic
inflammatory response syndrome (SIRS) which damages
multiple organs due to an influx of inflammatory cells from the
circulation. In this study, we evaluated the effect of tadalafil, a
phoshodiesterase inhibitor, against spinal cord, kidney and
bladder damage in experimental animal model of spinal cord
injury. Male Wistar albino rats were divided into sham-operated
control, and either vehicle or tadalafil-treated SCI groups. In
order to induce SCI, a standard weight-drop method that
induced a moderately severe injury (100 g/cm force) at T10,
was used. Injured animals were given either 10 mg/kg tadalafil
or vehicle 15 minutes post injury and repeated daily for seven
days. After decapitation spinal cord, kidney and bladder tissue
samples were obtained to examine oxidative tissue injury;
malondialdehyde (MDA) and glutathione (GSH) levels, and
superoxide dismutase (SOD), myeloperoxidase (MPO) and
caspase-3 activities. Tissues were also examined histologically.
In the injured animals, MDA levels MPO and caspase-3
activities in tissues were found significantly increased while
tadalafil treatment reversed these increases. On the other hand
SCI-induced decreases in GSH levels and SOD activities were
also reversed with tadalafil treatment. According to the results,
tadalafil exerts beneficial effects against SCI-induced
oxidative damage in spinal cord and also in remote organs
such as kidney and bladder tissues through its antiinflammatory
and antioxidant effects.
Key words: tadalafil; spinal cord
Keywords
References
- Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 2002; 26:238-55.
- Jia Z, Zhu H, Li J, Wang X, Misra H, Li Y. Oxidative stress in spinal cord injury and antioxidant-based intervention. Spinal Cord 2012;50:264-74.
- Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC. Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 2005; 102:3483-8.
- Genovese T, Mazzon E, Muia C, Bramanti P, De Sarro A, Cuzzocrea S. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005;38:198-208.
- Erşahin M, Çevik Ö, Akakın D, Şener A, Özbay L, Yegen BC, Şener G. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Prostaglandins Other Lipid Mediat 2012;99:131-9.
- Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 2006;50:1194-207; discussion 120
- Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol 2000;36:845-51.
- Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 2003;107:3230-5.
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
İlker Tınay
This is me
Cem Akbal
This is me
Mehmet Erşahin
This is me
Özge Çevik
This is me
Selin Çadırcı
This is me
Özlem Çilingir
This is me
Şule Çetinel
This is me
Göksel Şener
This is me
Publication Date
May 16, 2014
Submission Date
May 16, 2014
Acceptance Date
-
Published in Issue
Year 2014 Volume: 18 Number: 2